[English] 日本語
Yorodumi- PDB-9oo1: Influenza A Virus Group 2 Hemagglutinin (H7, Strain SH13) in Comp... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9oo1 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Influenza A Virus Group 2 Hemagglutinin (H7, Strain SH13) in Complex with a Potent Small-Molecule Entry Inhibitor ING-16-36 | ||||||||||||||||||||||||
Components |
| ||||||||||||||||||||||||
Keywords | VIRAL PROTEIN/INHIBITOR / Influenza A Virus / Hemagglutinin / Complex / Small-Molecule Inhibitor / Entry / ING-16-36 / VIRAL PROTEIN-INHIBITOR complex | ||||||||||||||||||||||||
| Function / homology | Function and homology informationviral budding from plasma membrane / clathrin-dependent endocytosis of virus by host cell / host cell surface receptor binding / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane / virion membrane / membrane Similarity search - Function | ||||||||||||||||||||||||
| Biological species | ![]() Influenza A virus | ||||||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.76 Å | ||||||||||||||||||||||||
Authors | Xu, Y. / Xu, K. | ||||||||||||||||||||||||
| Funding support | United States, 1items
| ||||||||||||||||||||||||
Citation | Journal: Proc Natl Acad Sci U S A / Year: 2025Title: Mechanistic insights into the small-molecule inhibition of influenza A virus entry. Authors: Yan Xu / Varada Anirudhan / Irina N Gaisina / Haijuan Du / Saad Alqarni / Terry W Moore / Michael Caffrey / Balaji Manicassamy / Tongqing Zhou / Lijun Rong / Kai Xu / ![]() Abstract: Influenza A virus (IAV) is a zoonotic pathogen responsible for seasonal and pandemic flu. The extensive genetic and antigenic diversity within and between IAV phylogenetic groups presents major ...Influenza A virus (IAV) is a zoonotic pathogen responsible for seasonal and pandemic flu. The extensive genetic and antigenic diversity within and between IAV phylogenetic groups presents major challenges for developing universal vaccines and broad-spectrum antiviral therapies. Current interventions provide limited protection due to the virus's high mutation rate and capacity for immune evasion. Recent advancements in viral hemagglutinin (HA)-targeting small-molecule entry inhibitors offer a promising avenue to overcome these limitations. Here, we present structural and functional analyses of two group 2 HA-specific small-molecule inhibitors recently identified by our team. Cryogenic electron microscopy (cryo-EM) structures revealed that these inhibitors bind a conserved pocket within the HA stalk, likely interfering with the conformational rearrangements necessary for membrane fusion and viral entry. Structure-guided mutagenesis confirmed the critical roles of key interacting residues and uncovered distinct resistance profiles between the two compounds, as well as in comparison to Arbidol, a previously reported HA inhibitor. Notably, our structural analysis highlights intrinsic barriers to achieving cross-group inhibition with current small-molecule designs. To address this, we propose an alternative strategy for broadening antiviral coverage. Together, these findings provide mechanistic insights into IAV entry inhibition and a foundation for the rational design of next-generation anti-influenza therapeutics. | ||||||||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9oo1.cif.gz | 301.6 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9oo1.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 9oo1.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 9oo1_validation.pdf.gz | 1.6 MB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 9oo1_full_validation.pdf.gz | 1.6 MB | Display | |
| Data in XML | 9oo1_validation.xml.gz | 53.1 KB | Display | |
| Data in CIF | 9oo1_validation.cif.gz | 75.4 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/oo/9oo1 ftp://data.pdbj.org/pub/pdb/validation_reports/oo/9oo1 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 70658MC ![]() 9onzC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
| #1: Protein | Mass: 36809.652 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Influenza A virus / Gene: HA / Production host: Homo sapiens (human) / References: UniProt: A0A067Y6L0#2: Protein | Mass: 19850.803 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Influenza A virus / Gene: HA / Production host: Homo sapiens (human) / References: UniProt: A0A067Y6L0#3: Polysaccharide | #4: Sugar | ChemComp-NAG / #5: Chemical | Mass: 355.864 Da / Num. of mol.: 3 / Source method: obtained synthetically / Formula: C19H22ClN5 / Feature type: SUBJECT OF INVESTIGATION Has ligand of interest | Y | Has protein modification | Y | |
|---|
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Influenza A virus / Type: VIRUS / Entity ID: #1-#2 / Source: RECOMBINANT |
|---|---|
| Source (natural) | Organism: ![]() Influenza A virus |
| Source (recombinant) | Organism: Homo sapiens (human) |
| Details of virus | Empty: YES / Enveloped: YES / Isolate: STRAIN / Type: VIRION |
| Buffer solution | pH: 7.2 / Details: 5mM HEPES buffer pH7.2, 150nM NaCl |
| Specimen | Conc.: 1 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES Details: 1mg/ml in HBS buffer, purfied from HEK293 recombinant expression and purified with NiNTA resin via Hisx6 tag |
| Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE / Humidity: 95 % / Chamber temperature: 273 K |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 81000 X / Nominal defocus max: 3000 nm / Nominal defocus min: 500 nm |
| Specimen holder | Cryogen: NITROGEN |
| Image recording | Electron dose: 50 e/Å2 / Film or detector model: GATAN K3 BIOCONTINUUM (6k x 4k) |
-
Processing
| EM software |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| Particle selection | Num. of particles selected: 4709508 | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 2.76 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 195885 / Symmetry type: POINT | ||||||||||||||||||||||||
| Atomic model building | B value: 112 / Protocol: OTHER | ||||||||||||||||||||||||
| Atomic model building | PDB-ID: 8TNL Accession code: 8TNL / Details: complete model of PDB 8TNL / Source name: PDB / Type: experimental model | ||||||||||||||||||||||||
| Refinement | Highest resolution: 2.76 Å Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi




Influenza A virus
United States, 1items
Citation



PDBj






Homo sapiens (human)

FIELD EMISSION GUN
